INTEGRATED BIOPHARMA INC Annual Operating Lease, Payments in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Integrated Biopharma Inc quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2024.
  • Integrated Biopharma Inc Operating Lease, Payments for the quarter ending September 30, 2024 was $236K, a 10.9% decline year-over-year.
  • Integrated Biopharma Inc annual Operating Lease, Payments for 2024 was $1.06M, a 7.28% increase from 2023.
  • Integrated Biopharma Inc annual Operating Lease, Payments for 2023 was $989K, a 52.2% increase from 2022.
  • Integrated Biopharma Inc annual Operating Lease, Payments for 2022 was $650K, a 2.11% decline from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.06M +$72K +7.28% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-20
2023 $989K +$339K +52.2% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-20
2022 $650K -$14K -2.11% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-15
2021 $664K +$7K +1.07% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-13
2020 $657K $0 0% Jul 1, 2019 Jun 30, 2020 10-K 2021-09-02
2019 $657K Jul 1, 2018 Jun 30, 2019 10-K 2020-09-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.